Exane Derivatives’s Griffon GFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$216K Sell
7,702
-500
-6% -$12.6K 0.12% 152
2022
Q1
$164K Sell
8,202
-3,556
-30% -$82.1K 0.05% 383
2021
Q4
$335K Sell
11,758
-371
-3% -$9.9K 0.08% 245
2021
Q3
$298K Buy
12,129
+2,449
+25% +$58.4K 0.07% 290
2021
Q2
$238K Buy
+9,680
New +$258K 0.05% 353

Other funds holding GFF

Exane Derivatives's GFF Position: Q2 2022 in Review

Exane Derivatives reduced its Griffon (GFF) stake by 6.1% in Q2 2022, selling an estimated $12.6K and leaving 7,702 shares worth $216K. The position accounts for 0.12% of the portfolio, ranked #152.

Exane Derivatives first reported a position in GFF in Q2 2021 and has held it in 5 quarters since. The position peaked at $335K in Q4 2021. 193 funds tracked by Wall St. Rank hold GFF as of Q2 2022.

  • Exane Derivatives held 7,702 shares of Griffon worth $216K as of Q2 2022.
  • Exane Derivatives sold 500 Griffon shares in Q2 2022, an estimated $12.6K.
  • Griffon made up 0.12% of Exane Derivatives's portfolio in Q2 2022, its #152 holding.
  • Exane Derivatives first reported a position in Griffon in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Griffon position peaked at $335K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Griffon as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.